Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. EGFR inhibitors as first-line therapy in advanced non-small cell lung cancer
Your Article Summary
See Latest ArticlesUsing Complementary and Alternative Medicines to Target the Host Response during Severe Influenza
Evidence-based Complementary and Alternative Medicine , 10/05/09
Alleva LM et al. – The example given here of an ancient Chinese medicine formula used to treat influenza containing nine (out of 11) herbs with anti–inflammatory properties provides compelling evidence that the way forward for the treatment of influenza in a pandemic should be immunomodulation. The host response is targeted, rather than the virus itself. The authors' observation that treatment of influenza virus–infected mice with a pharmaceutical used in humans, the lipid–lowering and immunomodulatory PPAR alpha agonist gemfibrozil, resulted in significantly decreased influenza–induced mortality, further shows that targeting the host response is a valid possibility. The natural immunomodulatory agent biochanin A from Red Clover, which is both a PPAR alpha and PPAR gamma agonist, could have similar effects to gemfibrozil on the course of influenza disease in vivo. Chinese herbs such as A. sinensis and S. miltiorrhiza which independently reduce secretion of the novel inflammatory cytokine HMGB1, and glycyrrhizin from liquorice root, which binds to HMGB1 and inactivates its activity, provide another avenue for investigation, as does the establishment of the role of HMGB1 in severe influenza.
Lisa Alleva, 10/05/09
| Immunomodulatory treatments could be harnessed to treat severe influenza. We propose that complementary and alternative medicine, as well as conventional medicine, should be explored for therapies, and that special attention should be payed to those therapies that specifically tone-down the pro-inflammatory response. |
Related Articles
H1N1 Vaccine Production, Availability Increasing Slowly
American Family Physician, 11/02/09
Relevance Score: 88%
Update on 2009 pandemic influenza A (H1N1) virus
Cleveland Clinic Journal of Medicine, 10/05/09
Relevance Score: 84%
The first Pandemic of the 21st Century: A Review of the 2009 Pandemic Variant Influenza A (H1N1) Virus
Postgraduate Medicine, 10/02/09
Relevance Score: 84%
Bacterial Coinfections in Lung Tissue Specimens From Fatal Cases of 2009 Pandemic Influenza A (H1N1)--United States, May-August 2009
JAMA, 11/04/09
Relevance Score: 83%
Detection and subtyping of influenza A virus based on a short oligonucleotide microarray
Diagnostic Microbiology and Infectious Disease, 10/20/09
Relevance Score: 83%
Today in Pulm/Thoracic Infections...keeping you current
Receive free subspecialty "5-minute updates" via email
Comparison between concentrations of amphotericin B in infected lung lesion and in uninfected lung tissue in a patient treated with liposomal amphotericin B
International Journal of Infectious Diseases, 12/04/09
Point-of-Care Testing for Pandemic Influenza and Biothreats
Disaster Medicine and Public Health Preparedness, 12/04/09
T-Cell Deficiency in Dual Infection With Cytomegalovirus and Pneumocystis jiroveci Pneumonia
Pediatric Asthma, Allergy & Immunology, 12/04/09
Sponsor
Article Search
Sponsor